Treatment Options for Anxiety and Major Depressive Disorder (MDD)

Introduction to Treatment Options

Both pharmacologic and nonpharmacologic treatments offer similar benefits for anxiety and MDD, with treatment selection based on patient preferences, adverse event profiles, and symptom severity 1, 2, 3

Second-generation antidepressants (SGAs) are commonly prescribed first-line medications for both MDD and anxiety disorders, including selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and other SGAs such as bupropion, mirtazapine, and trazodone 3, 4, 5
More than 60% of patients experience at least one adverse effect with SGAs, and up to 70% do not achieve remission during initial treatment 1, 2
Common side effects of SGAs include sexual dysfunction, gastrointestinal symptoms, and sleep disturbances 1

Psychological interventions, such as cognitive behavioral therapy (CBT), interpersonal therapy, psychodynamic therapies, and acceptance and commitment therapy, have similar efficacy to medications for anxiety and MDD 1, 2, 5, 6, 7
Complementary and alternative medicine (CAM) options, including acupuncture, meditation, omega-3 fatty acids, S-adenosyl-L-methionine (SAMe), and St. John's wort, may be beneficial for mild to moderate depression 1, 5, 7

Combined therapy options, such as SGA plus CBT or SGA plus acupuncture, may improve treatment response and remission rates compared to monotherapy 1, 3, 7

Patients with comorbid anxiety and depression may experience a more chronic course of illness, increased suicidal thoughts and behaviors, and greater functional impairment, and may require modified treatment approaches 2, 5

Acute phase treatment typically lasts 6-12 weeks, and continuation phase lasts 4-9 months, with regular monitoring using validated tools 5

Treatment selection should consider adverse event profiles, patient preferences, and symptom severity, with a focus on options with the most reliable evidence 1, 3, 6